These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 1022182)
1. [Effect of SRIF (somatostatin) on human somatroptropic adenomas in vitro ultrastructure and growth hormone production (author's transl)(proceedings)]. Peillon F; Garnier PE; Brandi A; Rivaille P; Chaussain JL Ann Endocrinol (Paris); 1976; 37(4):271-2. PubMed ID: 1022182 [No Abstract] [Full Text] [Related]
2. Effect of bromocriptine, somatostatin, and oestradiol-17 beta on hormone secretion and ultrastructure of human pituitary tumours in vitro. Prysor-Jones RA; Kennedy SJ; O'Sullivan JP; Jenkins JS Acta Endocrinol (Copenh); 1981 Sep; 98(1):14-23. PubMed ID: 6116372 [TBL] [Abstract][Full Text] [Related]
3. [Lectin binding sites of the human pituitary adenoma cells as revealed by the ferritin- and horseradish peroxidase-labeled techniques (author's transl)]. Hori T; Matsutani M; Terao H; Tamura A; Sano K; Nishiyama F; Hirano H Neurol Med Chir (Tokyo); 1979 Dec; 19(12):1183-95. PubMed ID: 94659 [No Abstract] [Full Text] [Related]
6. [Prolactin secretion and synthesis by human somatotropin adenomas: in vitro effect of somatostatin (SRIF) (author's transl)]. Peillon F; Cesselin F; Garnier PE; Brandi AM; Donnadieu M; Mauborgne A; L'Hermitte M Ann Endocrinol (Paris); 1977; 38(2):165-6. PubMed ID: 900872 [TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor subtype gene expression in pituitary adenomas. Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115 [TBL] [Abstract][Full Text] [Related]
8. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly. Lamberts SW; Verleun T; Oosterom R J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175 [TBL] [Abstract][Full Text] [Related]
9. Pituitary growth hormone cell adenoma with cytoplasmic tubular aggregates in the capillary endothelium. Kovacs K; Horvath E; Pritzker KP; Schwartz ML Acta Neuropathol; 1977 Jan; 37(1):77-9. PubMed ID: 190850 [TBL] [Abstract][Full Text] [Related]
10. Pituitary adenomas: clinicopathological and immunohistochemical study. Martinez AJ; Lee A; Moossy J; Maroon JC Ann Neurol; 1980 Jan; 7(1):24-36. PubMed ID: 6244771 [No Abstract] [Full Text] [Related]
11. Somatostatin receptor subtype 1 selective activation in human growth hormone (GH)- and prolactin (PRL)-secreting pituitary adenomas: effects on cell viability, GH, and PRL secretion. Zatelli MC; Piccin D; Tagliati F; Ambrosio MR; Margutti A; Padovani R; Scanarini M; Culler MD; degli Uberti EC J Clin Endocrinol Metab; 2003 Jun; 88(6):2797-802. PubMed ID: 12788890 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous measurement of changes in the membrane potential and the intracellular Ca2+ concentration caused by somatostatin in human GH-producing pituitary tumor cells. Yamashita N; Takano K; Teramoto A; Tatakura K; Ogata E Endocrinol Jpn; 1992 Oct; 39(5):491-7. PubMed ID: 1362150 [TBL] [Abstract][Full Text] [Related]
13. [Clinical, hormonal and ultrastructural correlations of hypophysary adenoma. Study of 9 cases]. Scanarini M; Mingrino S; Baroni A Acta Neurol (Napoli); 1976; 31(1):43-5. PubMed ID: 970258 [No Abstract] [Full Text] [Related]
14. [Clinical study on functioning pituitary adenomas (prolactin secreting and growth hormone secreting adenomas) (author's transl)]. Mori S; Matsumura S; Kodama Y; Uozumi T; Watanabe M Neurol Med Chir (Tokyo); 1976 May; 16(3 pt 2):215-25. PubMed ID: 62301 [No Abstract] [Full Text] [Related]
15. [Immunohistochemical studies on the functioning pituitary adenomas (author's transl)]. Teramoto A No To Shinkei; 1980 Nov; 32(11):1163-74. PubMed ID: 7006647 [No Abstract] [Full Text] [Related]
16. Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro. Ćawnicka H; Pisarek H; Kunert-Radek J; Pawlikowski M Neuro Endocrinol Lett; 2008 Feb; 29(1):113-6. PubMed ID: 18283262 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors. Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020 [TBL] [Abstract][Full Text] [Related]
18. [Electron microscopic study of human prolactin producing pituitary adenoma (author's transl)]. Shimizu T; Kimura R; Tamura M; Takeda F Neurol Med Chir (Tokyo); 1981 Dec; 21(12):1219-28. PubMed ID: 6173784 [No Abstract] [Full Text] [Related]